Leaderboard

En | De
No articles selected!     View Cart  
You are here: Urology-Nephrology » Neoplasia/BPH 10. February 2025
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 8700  Previews Next
   
   Articles 1 - 20 / 173994  
   
Integrating Prostate Surface Membrane Antigen-PET into Clinical Practice for Prostate Cancer.
PET Clin
Wang JH, Shi X, Tran PT, Sutera P.
PMID: 39924369 [PubMed - as supplied by publisher]


Revolutionizing Prostate Cancer Therapy: Artificial intelligence - based Nanocarriers for Precision Diagnosis and Treatment.
Crit Rev Oncol Hematol
Shirzad M, Salahvarzi A, Razzaq S, Javid-Naderi MJ, Rahdar A, Fathi-Karkan S, Ghadami A, Kharaba Z, Ferreira LFR.
PMID: 39923922 [PubMed - as supplied by publisher]


More than three in five kidney cancer diagnoses in the UK are incidental.
Lancet Oncol
Gourd E.
PMID: 39923783 [PubMed - as supplied by publisher]


Assessment of bone mineral density in men with de novo metastatic castration-sensitive prostate cancer treated with or without abiraterone acetate plus prednisone in the PEACE-1 phase 3 trial.
Eur J Cancer
Roubaud G, Kostine M, McDermott RS, Bernard-Tessier A, Maldonado X, Silva M, Fléchon A, Berthold DR, Ronchin P, Tombal BF, Mourey L, Gravis G, Escande A, Abadie-Lacourtoisie S, Maurina T, Climent MA, Ribault H, Bossi A, Foulon S, Fizazi K.
PMID: 39923274 [PubMed - as supplied by publisher]


The real-world study of Qian Lie Shu Tong Jiao Nang combined with finasteride tablets in the treatment of benign prostatic hyperplasia.
Pak J Pharm Sci
Tao G, Wang X.
PMID: 39923151 [PubMed - indexed for MEDLINE]


Association between magnesium depletion score and prostate cancer.
Sci Rep
Gong H, Lin X, Huang S.
PMID: 39922926 [PubMed - indexed for MEDLINE]


Re: Noel W. Clarke, Andrew J. Armstrong, Mototsugu Oya, et al. Efficacy and Safety of Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone in the First-line Treatment of Patients with Asymptomatic/Mildly Symptomatic and Symptomatic Metastatic Castration-resistant Prostate Cancer: Analyses from the Phase 3 PROpel Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2024.09.013.
Eur Urol Focus
Yuan S, Chen P, Sun F, Li T.
PMID: 39922754 [PubMed - as supplied by publisher]


Reply to: Francesco Montorsi, Francesco Montorsi, Giuseppe Rosiello, Marco Moschini, Andrea Salonia, and Alberto Briganti's letter to the Editor re: Akihiro Matsukawa, Takafumi Yanagisawa, Marcin Miszczyk, et al. Trimodality Therapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Matched Cohort Studies. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2024.11.003.
Eur Urol Focus
Matsukawa A, Yanagisawa T, Miszczyk M, Kimura T, Shariat SF.
PMID: 39922752 [PubMed - as supplied by publisher]


Re: Bertrand F. Tombal, Francisco Gomez-Veiga, Alvaro Gomez-Ferrer, et al. A Phase 2 Randomized Open-label Study of Oral Darolutamide Monotherapy Versus Androgen Deprivation Therapy in Men with Hormone-sensitive Prostate Cancer (EORTC-GUCG 1532). Eur Urol Oncol 2024;7:1051-60.
Eur Urol Oncol
Montorsi F, Gandaglia G, Barletta F, Briganti A.
PMID: 39922738 [PubMed - as supplied by publisher]


Endocrinological toxicities related to immunotherapy combinations for advanced renal cell carcinoma: practical expert-based management recommendations.
Crit Rev Oncol Hematol
Colombo C, Leo S, Campisi I, Palesandro E, Turco F, Buttigliero C, Fugazzola L, Tucci M.
PMID: 39922397 [PubMed - as supplied by publisher]


A Phase 2 Trial of Radium(223) and Stereotactic Ablative Radiotherapy in Hormone-Naïve Men with Oligometastatic Prostate Cancer to Bone: The RadSABR study.
Int J Radiat Oncol Biol Phys
Tward J, Lloyd S, Johnson S, Dechet C, Nei BO, Maughan B, Swami U, Gupta S, Sanchez A, Kokeny K, Agarwal N.
PMID: 39922320 [PubMed - as supplied by publisher]


The Benefit of Short-Term Androgen Deprivation Therapy with Radiotherapy for Intermediate-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys
Patel KR, Spratt DE, Tran PT, Krauss DJ, D'Amico AV, Nguyen PL.
PMID: 39922318 [PubMed - as supplied by publisher]


Prognostic Value of Cribriform and Intraductal Carcinoma in Grade Group 2 Prostate Cancer with and without Synchronous Nodal Metastases at Radical Prostatectomy: Results from a Case-Control Matched, Multicenter Study.
Urology
de Barros HA, Downes MR, Droghetti M, Bekers EM, Giunchi F, Brunocilla E, Schiavina R, van der Kwast TH, van Leeuwen PJ, van der Poel HG.
PMID: 39922236 [PubMed - as supplied by publisher]


Comparative efficacy and safety of ablative therapies in the management of primary localised renal cell carcinoma: a systematic review and meta-analysis.
Lancet Oncol
Huang RS, Chow R, Benour A, Chen D, Boldt G, Wallis CJD, Swaminath A, Simone CB 2nd, Lock M, Raman S.
PMID: 39922208 [PubMed - as supplied by publisher]


Prostate cancer screening in the Middle East and North Africa: a cross-sectional study on current practices.
JNCI Cancer Spectr
Aynaci O, Tuac Y, Mula-Hussain L, Hammoudeh L, Obeidat S, Abu Abeelh E, Ibrahim AH, Mohammadipour S, Alali B, Jdaini A, Barki A, Mejri N, Alhaddad Z, Pervez N, Al Hussain H, Kadri M, Elfagieh MA, Bounedjar A, Junaid M, Badheeb AM, Abu Ghida I, Moningi S, Leeman JE, Orio PF, Nguyen PL, D'Amico AV, Sayan M.
PMID: 39921899 [PubMed - as supplied by publisher]


Digital Pathology Allows for Global Second Opinions for Urologic Malignancies.
Curr Urol Rep
Shepherd DJ, Gordetsky JB.
PMID: 39921827 [PubMed - indexed for MEDLINE]


Physician and Patient Preferences for the Treatment of Metastatic Castration-Sensitive and Castration-Resistant Prostate Cancer: A Best-Worst Scaling Study in Japan.
Oncol Ther
Kimura T, Takahashi N, Asakawa K, Saito A, Mitomi T, Lee T, Matsumura M.
PMID: 39921822 [PubMed - as supplied by publisher]


Adjunctive diagnostic tool for histopathological classification of congenital mesoblastic nephroma based in molecular genetic findings.
J Cancer Res Clin Oncol
Hamada H, Kohashi K, Iwasaki T, Hashisako M, Hino Y, Fukuhara M, Kamouchi A, Kawakubo N, Tajiri T, Oda Y.
PMID: 39921750 [PubMed - indexed for MEDLINE]


Impact of dialysis on intravesical recurrence and survival outcomes in upper tract urothelial cancer patients undergoing radical nephroureterectomy.
Ren Fail
Hsieh CC, Li CC, Juan YS, Li WM, Wu WJ, Chien TM.
PMID: 39920881 [PubMed - indexed for MEDLINE]


Targeting ferroptosis in prostate cancer management: molecular mechanisms, multidisciplinary strategies and translational perspectives.
J Transl Med
Yang H, Zhang X, Jia Z, Wang H, Wu J, Wei X, Huang Y, Yan W, Lin Y.
PMID: 39920771 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 173994    Page 1 of 8700  Previews Next

 
Rect Bottom
Adserver Footer
 

Username

Password

 

 

Forgot your username or password?

 

New User? Sign Up

Register to My Medline!

 

Learn more about the My Medline experience

more >>

  Time frame  
   

Sky right 1